Musculoskeletal Research Laboratory of Department of Orthopedics & Traumatology, Innovative Orthopaedic Biomaterial & Drug Translational Research Laboratory, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, 999077, China.
Department of Orthopaedics & Traumatology, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, SAR, 999077, China.
Adv Sci (Weinh). 2022 Jul;9(21):e2202102. doi: 10.1002/advs.202202102. Epub 2022 Jun 2.
Peripheral nerve injury is a challenging orthopedic condition that can be treated by autograft transplantation, a gold standard treatment in the current clinical setting. Nevertheless, limited availability of autografts and potential morbidities in donors hampers its widespread application. Bioactive scaffold-based tissue engineering is a promising strategy to promote nerve regeneration. Additionally, magnesium (Mg) ions enhance nerve regeneration; however, an effectively controlled delivery vehicle is necessary to optimize their in vivo therapeutic effects. Herein, a bisphosphonate-based injectable hydrogel exhibiting sustained Mg delivery for peripheral nerve regeneration is developed. It is observed that Mg promoted neurite outgrowth in a concentration-dependent manner by activating the PI3K/Akt signaling pathway and Sema5b. Moreover, implantation of polycaprolactone (PCL) conduits filled with Mg -releasing hydrogel in 10 mm nerve defects in rats significantly enhanced axon regeneration and remyelination at 12 weeks post-operation compared to the controls (blank conduits or conduits filled with Mg -absent hydrogel). Functional recovery analysis reveals enhanced reinnervation in the animals treated with the Mg -releasing hydrogel compared to that in the control groups. In summary, the Mg -releasing hydrogel combined with the 3D-engineered PCL conduit promotes peripheral nerve regeneration and functional recovery. Thus, a new strategy to facilitate the repair of challenging peripheral nerve injuries is proposed.
周围神经损伤是一种具有挑战性的骨科疾病,可以通过自体移植物移植来治疗,这是当前临床环境中的黄金标准治疗方法。然而,自体移植物的有限可用性和供体的潜在病态限制了其广泛应用。基于生物活性支架的组织工程是促进神经再生的一种有前途的策略。此外,镁 (Mg) 离子可增强神经再生;然而,需要有效的控制释放载体来优化其体内治疗效果。本文开发了一种基于双膦酸盐的可注射水凝胶,可实现周围神经再生的持续 Mg 释放。研究发现,Mg 通过激活 PI3K/Akt 信号通路和 Sema5b,以浓度依赖的方式促进神经突生长。此外,在大鼠 10mm 神经缺损中植入填充有 Mg 释放水凝胶的聚己内酯 (PCL) 导管,与对照组(空白导管或填充无 Mg 水凝胶的导管)相比,在术后 12 周时显著增强了轴突再生和髓鞘形成。功能恢复分析显示,与对照组相比,接受 Mg 释放水凝胶治疗的动物具有更好的神经再支配。综上所述,Mg 释放水凝胶与 3D 设计的 PCL 导管相结合,可促进周围神经再生和功能恢复。因此,提出了一种促进治疗挑战性周围神经损伤的新策略。